Nyumbani › Magonjwa ya Mapafu ya Interstitial › Ohio
Majaribio ya kliniki ya Magonjwa ya Mapafu ya Interstitial katika jimbo la Ohio
Masomo 14 ya Magonjwa ya Mapafu ya Interstitial yanatafuta washiriki katika vituo vya jimbo la Ohio.
Miji katika jimbo la Ohio
Maandishi rasmi ya utafiti (Kiingereza)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University Hospitals Cleveland Medical Center, Cleveland
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT07540988Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA015, Cincinnati
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT07179380LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Cincinnati Department of Internal Medicine Pulmonary, Critical Care & Sleep Medicine, Cincinnati
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 29 Sep 2026 · NCT05798923A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Cincinnati
InaajiriHatua 2/3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 8 Sep 2026 · NCT05878717A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Cincinnati Medical Center, Cincinnati
InaajiriHatua 2
Umri 40 na zaidi · Jinsia zote · Imesasishwa 4 Sep 2026 · NCT06968845Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University Hospitals Cleveland Medical Center, Cleveland
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Cincinnati Medical Center, Cincinnati
- University Hospitals Cleveland Medical Center, Cleveland
- The Cleveland Clinic, Cleveland
- na zaidi ya 1
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 26 Ago 2026 · NCT06388421Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Cleveland Clinic, Cleveland
- The Ohio State University, Columbus
InaajiriUtafiti wa uchunguzi
Umri 21 na zaidi · Jinsia zote · Imesasishwa 12 Ago 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Ohio State University, Columbus
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT07175038Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Cincinnati Children's Hospital Medical Center, Cincinnati
InaajiriHatua 2
Umri 4 na zaidi · Jinsia zote · Imesasishwa 22 Jul 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Cincinnati Medical Center, Cincinnati
- St. Luke's Univeristy Health Network-Pulmonary & Critical Care, Cincinnati
- The Ohio State University Wexner Medical CEnter, Columbus
- na zaidi ya 1
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT05943535A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- GSK Investigational Site, Columbus
InaajiriHatua 1Wajitolea wenye afya wanakaribishwa
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT06576271TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- Cincinnati Children's Hospital Medical Center, Cincinnati
InaajiriUtafiti wa uchunguzi
Hadi umri 24 · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT04098445Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
- aTyr Investigative Site, Cleveland
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 7 Mei 2025 · NCT05892614Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.